Skip to content

Author

Bruno E. Correia

We have 7 of 149 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Computational design of protein conformational landscapes for metamorphic behavior

Protein function is governed by its three-dimensional structure and intrinsic conformational dynamics. Recent advances in generative protein design have enabled the computational design of increasingly diverse protein structures. However, designing sequences that populate multiple conformations and controlling their re...

Alisa Khramushin, Maddalena Elia, Christian Schellhaas et al. · 0 citations
#protein folding Open access Oct 2026

De novo design of light-controlled conformational protein switches

Light-responsive proteins offer the ability to control biology at an unmatched resolution. Yet, optogenetics is limited to a relatively small number of natural and engineered photoreceptors. The design of light-responsive proteins with native-like complexity is challenging as they must incorporate a light-responsive ch...

Alexander T. Hilditch, N. Goldbach, Chen-Xuan Liu et al. · 0 citations
#reinforcement learning Open access Oct 2026

Reinforcement Learning for Aligning Structure-Based Molecular Generation toward Make-on-Demand Chemical Spaces

Re reinforcement learning is applied to a pocket-conditioned generative molecular model, demonstrating that RL alignment can substantially improve the experimental accessibility of SBDD candidates without sacrificing structural or chemical quality.

Rebecca M. Neeser, M. Yiğit, Adrian W. Dobbelstein et al. · 0 citations
Open access Sep 2026

A Unified 3D Generative Model for Synthesizable Structure-Based Drug Design

LDDM (Large Drug Discovery Model) is introduced, a generative framework that supports a range of drug discovery tasks, including constrained and unconstrained docking, fragment linking and growing, and de novo design, and a programmable design algorithm that enables accurate design of synthetically accessible compounds...

Ilia Igashov, Arne Schneuing, Adrian W. Dobbelstein et al. · 0 citations
Open access Aug 2026

Proteome-wide identification of the druggable CRBN interactome.

This pipeline identified 6 known and 43 novel CRBN-pomalidomide binders, including orthogonally validated hits that provide privileged starting points for MGD development, and expects this binding-focused workflow to be applicable to other MGD-E3 ligase systems, potentially extending the scope of this emerging drug cla...

Pius Galli, Shuhao Xiao, Y. Meng et al. · 1 citation
Open access Aug 2026

Mimic antibodies: leveraging ligand mimicry for epitope-targeted antibody discovery

The concept of mimic antibodies–antibodies that recapitulate the binding mode of a target’s cognate ligand is investigated and established as a promising strategy for rational antibody selection, engineering, and design, with broad implications for therapeutic antibody development and drug discovery.

Brennan Abanades, Joanan López-Morales, Ivana Tanasijević et al. · 2 citations
Open access Jul 2026

The Human Bindome: A Proteome-scale Atlas of Designed Binder Candidates

The Human Bindome is presented, a proteome-scale atlas of high-confidence in silico protein binder candidates that positions the Bindome as a resource of genetically encodable perturbagens for site-specific, modular control of protein function.

Julius Wenckstern, Anna M. Díaz-Rovira, Julia A. Kuhn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.